SIMG
ALXN

Stephens Investment Management Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Stephens Investment Management Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-37,037
Closed -$6.8M – 196
2021
Q2 		$6.8M Buy
37,037
+1,805
+5% +$310K 0.09% 156
2021
Q1 		$5.39M Buy
35,232
+1,730
+5% +$268K 0.08% 161
2020
Q4 		$5.23M Sell
33,502
-567
-2% -$72.9K 0.08% 158
2020
Q3 		$3.9M Sell
34,069
-744
-2% -$80.3K 0.07% 156
2020
Q2 		$3.91M Buy
34,813
+4,737
+16% +$503K 0.07% 151
2020
Q1 		$2.7M Sell
30,076
-1,590
-5% -$156K 0.07% 145
2019
Q4 		$3.42M Buy
31,666
+23
+0.1% +$2.46K 0.06% 151
2019
Q3 		$3.1M Buy
31,643
+8,007
+34% +$903K 0.06% 150
2019
Q2 		$3.1M Buy
23,636
+2,477
+12% +$319K 0.06% 163
2019
Q1 		$2.86M Buy
21,159
+652
+3% +$81.1K 0.06% 163
2018
Q4 		$2M Sell
20,507
-957
-4% -$113K 0.05% 163
2018
Q3 		$2.98M Buy
21,464
+750
+4% +$94.1K 0.06% 161
2018
Q2 		$2.52M Buy
20,714
+246
+1% +$28.8K 0.05% 160
2018
Q1 		$2.28M Buy
20,468
+2,756
+16% +$329K 0.05% 166
2017
Q4 		$2.12M Buy
17,712
+1,461
+9% +$178K 0.05% 173
2017
Q3 		$2.28M Hold
16,251
– – 0.05% 166
2017
Q2 		$1.98M Buy
16,251
+4,044
+33% +$471K 0.05% 167
2017
Q1 		$1.48M Buy
12,207
+406
+3% +$52.3K 0.04% 169
2016
Q4 		$1.44M Buy
11,801
+5
+0% +$612 0.04% 165
2016
Q3 		$1.45M Buy
11,796
+6,706
+132% +$863K 0.04% 162
2016
Q2 		$594K Sell
5,090
-640
-11% -$90.8K 0.02% 172
2016
Q1 		$798K Sell
5,730
-330
-5% -$48.5K 0.03% 165
2015
Q4 		$1.16M Sell
6,060
-335
-5% -$58.5K 0.04% 162
2015
Q3 		$1M Sell
6,395
-395
-6% -$72.1K 0.04% 168
2015
Q2 		$1.23M Buy
6,790
+185
+3% +$31.9K 0.04% 170
2015
Q1 		$1.15M Buy
6,605
+470
+8% +$85.1K 0.03% 167
2014
Q4 		$1.14M Buy
6,135
+65
+1% +$12K 0.03% 168
2014
Q3 		$1.01M Buy
6,070
+160
+3% +$26.3K 0.03% 180
2014
Q2 		$923K Sell
5,910
-250
-4% -$39.5K 0.03% 189
2014
Q1 		$937K Sell
6,160
-1,155
-16% -$184K 0.03% 190
2013
Q4 		$973K Buy
7,315
+1,380
+23% +$166K 0.03% 181
2013
Q3 		$689K Buy
5,935
+50
+0.8% +$5.49K 0.02% 189
2013
Q2 		$543K Buy
+5,885
New +$567K 0.03% 185

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return